ストックスクリーナーアプリを入手
0.8725
3.32%
0.028
アフターアワーズ：
2.59
1.7175
+196.85%
前日終値:
$0.8445
開ける：
$0.8953
24時間の取引高:
100.99K
Relative Volume:
1.48
時価総額：
$31.57M
収益：
$3.34M
当期純損益:
$-7.35M
株価収益率:
-3.6861
EPS:
-0.2367
ネットキャッシュフロー:
$-4.63M
1週間 パフォーマンス:
+11.86%
1か月 パフォーマンス:
+3.92%
6か月 パフォーマンス:
-25.43%
1年 パフォーマンス:
-36.78%
1日の値動き範囲:
$0.8536
$0.9402
1週間の範囲:
$0.7544
$1.02
52週間の値動き範囲:
$0.711
$1.4495
Dyadic International Inc De Stock (DYAI) Company Profile
名前
Dyadic International Inc De
セクター
電話
561-743-8333
住所
1044 NORTH U.S. HIGHWAY ONE, JUPITER
Compare DYAI vs PSNYW, SHMD, GOODO, DWLD, QQQE
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| 1.69 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
5.30 | 493.05M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
7.42 | 364.76M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
19.92 | 372.90M | 0 | 0 | 0 | 0.00 |
DWLD
Davis Select Worldwide ETF
|
43.93 | 0 | 0 | 0 | 0 | 0.00 |
QQQE
Direxion NASDAQ-100 Equal Weigh
|
99.50 | 0 | 0 | 0 | 0 | 0.00 |
Dyadic International Inc De Stock (DYAI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-23 | 再開されました | H.C. Wainwright | Buy |
| 2025-09-08 | 開始されました | Craig Hallum | Buy |
| 2022-07-18 | ダウングレード | Dawson James | Buy → Neutral |
| 2021-12-17 | 開始されました | H.C. Wainwright | Buy |
Dyadic International Inc De (DYAI) 最新ニュース
Dyadic International Inc (DYAI) Q4 2025 Earnings Call Highlights: Navigating Transition with ... By GuruFocus - Investing.com Canada
Dyadic (DYAI) Q4 2025 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: Dyadic Q4 2025 reveals revenue decline, stock up 3.32% - Investing.com Australia
Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress - Yahoo Finance Singapore
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices - GlobeNewswire
Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 - GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th - GlobeNewswire
Decliners Report: Can Dyadic International Inc outperform under higher oil pricesWeekly Market Outlook & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Dyadic International Establishes At-the-Market Equity Offering Program - TipRanks
Animal-free enzyme from Dyadic and Fermbox targets gene therapy - Stock Titan
Dyadic Applied BioSolutions and Inzymes ApS Announce - GlobeNewswire
Alpha-Amylase Market Forecast Points Higher Toward 2035 Amid Sustainable Industrial ShiftNews and Statistics - IndexBox
Dyadic's Strategic Pivot: From Platform to Product - AD HOC NEWS
Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin - Yahoo Finance
Segmentation, Major Trends, and Competitive Overview of the Industrial Biocatalysts Market - openPR.com
Enzyme Engineering Market to Get an Explosive Growth | Novozymes - openPR.com
Dyadic International (NASDAQ:DYAI) Stock Passes Below Fifty Day Moving Average – Should You Sell? - Defense World
Dyadic International (NASDAQ:DYAI) Share Price Crosses Below 50 Day Moving Average – Should You Sell? - Defense World
Dyadic International’s Tiny Stock, Big Volatility: Can DYAI’s Latest Rally Really Last? - AD HOC NEWS
Enzyme Engineering Market Set for Rapid Growth and Trend - openPR.com
Dyadic International Inc. (NASDAQ:DYAI) Short Interest Up 25.7% in December - Defense World
iAccess Alpha’s Virtual Best Ideas Winter Investment Conference December 9-10, 2025 - Ventura County Star
Dyadic International Amends Convertible Notes, Extends Maturity Timeline - TipRanks
Dyadic International receives Nasdaq notice for minimum bid price deficiency - Investing.com
Dyadic International receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com UK
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets - GlobeNewswire
Analysis of Market Segmentation, Major Trends, and Competitive Dynamics in the Cellulase Market - openPR.com
Dyadic Applied BioSolutions Establishes Commercial - GlobeNewswire
Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins - Yahoo Finance
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025 - Finviz
Earnings call transcript: Dyadic’s Q3 2025 results miss forecasts, stock dips - Investing.com
Earnings call transcript: Dyadic's Q3 2025 results miss forecasts, stock dips - Investing.com UK
Industrial Enzymes Market worth $12.01 billion by 2030 - MarketsandMarkets
Dyadic International’s CRISPR Leap: Future Unveiled - timothysykes.com
iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025 - News & Observer
Dyadic (DYAI) and BRIG BIO ink alpha-lactalbumin pact for global nutrition - Stock Titan
DYAIDyadic International Inc., DE Stock Price and Quote - Finviz
Will Dyadic International Inc. stock beat EPS estimatesJuly 2025 Volume & Verified Stock Trade Ideas - moha.gov.vn
Taking on analysts’ expectations and winning: Apyx Medical Corp (APYX) - Setenews
A Look at Greenidge Generation Holdings Inc (GREE) Shares in the Recent Past Indicates Growth - Setenews
Bandera Partners LLC Has $1.37 Million Holdings in Dyadic International Inc. $DYAI - Defense World
AXQ Capital LP Sells 411 Shares of Acuity, Inc. $AYI - Defense World
What momentum shifts mean for Dyadic International Inc.Trade Volume Summary & Weekly Top Gainers Alerts - newser.com
Dyadic International’s Earnings Call: Cautious Optimism Amid Challenges - TipRanks
Dyadic International Inc De (DYAI) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):